Juan Macías, MD, PhD

CONTACT

Lead Sponsor

University of Seville

Collaborators

Age

All ages

Sex

ALL

Healthy Volunteers

No

•1. Treatment naive patients who received therapy with GLE/PIB or SOF/VEL between April 1st, 2018, and July 1st, 2023, receiving ≥ 1 comedication or recreational drug.
•2. Attended in a hospital with electronic clinical records allowing access to all clinical visits and prescribed medications, both in all hospitals and in primary care institutions of the corresponding Spanish region during the study period.

•Patients who meet any of the following criteria will be excluded from the study:
•1. HCV treatment-experienced patients will be excluded.
•2. Patients without any comedication or recreational drug use
•3. Those who have attended private health care